Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
- PMID: 15781636
- DOI: 10.1158/0008.5472.CAN-04-2781
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
Abstract
Elevated levels of the bioactive lipid lysophosphatidic acid (LPA) are detectable in the majority of patients with both early- and late-stage ovarian cancer, suggesting that LPA promotes early events in ovarian carcinoma dissemination. LPA contributes to the development, progression, and metastasis of ovarian cancer in part by inducing the expression of genes that contribute to proliferation, survival, or invasion, including cyclooxgenase-2 (COX-2) and matrix metalloproteinase-2 (MMP-2). We have previously shown that LPA promotes proMMP-2 activation and MMP-2-dependent migration and invasion in ovarian cancer cells. The purpose of the current study was to determine whether the effect of LPA on acquisition of the metastatic phenotype in ovarian cancer cells is mediated via a COX-2-dependent mechanism. Immunohistochemical analysis of 173 ovarian tumors showed strong COX-2 immunoreactivity in 63% of tumor specimens, including 50% of borderline tumors. LPA increased COX-2 protein expression in a time- and concentration-dependent manner in two of three immortalized borderline ovarian epithelial cells as well as in four of six ovarian cancer cell lines. This was accomplished by both activation of the Edg/LPA receptor and LPA-mediated transactivation of the epidermal growth factor receptor, which increased COX-2 expression via the Ras/mitogen-activated protein kinase pathway. COX-2 also played a role in LPA-induced invasion and migration, as treatment with the COX-2 specific inhibitor NS-398 reduced LPA-induced proMMP-2 protein expression and activation and blocked MMP-dependent motility and invasive activity. These data show that COX-2 functions as a downstream mediator of LPA to potentiate aggressive cellular behavior.
Similar articles
-
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.Cancer Res. 2001 Apr 1;61(7):3194-9. Cancer Res. 2001. PMID: 11306508
-
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.Clin Cancer Res. 2004 Jul 15;10(14):4670-9. doi: 10.1158/1078-0432.CCR-04-0315. Clin Cancer Res. 2004. PMID: 15269139
-
Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.Cancer Res. 2004 Jun 15;64(12):4209-17. doi: 10.1158/0008-5472.CAN-04-0060. Cancer Res. 2004. PMID: 15205333
-
Roles of LPA in ovarian cancer development and progression.Future Oncol. 2009 Dec;5(10):1659-73. doi: 10.2217/fon.09.120. Future Oncol. 2009. PMID: 20001802 Review.
-
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.Cancer Treat Res. 2002;107:259-83. doi: 10.1007/978-1-4757-3587-1_12. Cancer Treat Res. 2002. PMID: 11775454 Review.
Cited by
-
Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2.Oncol Lett. 2013 Mar;5(3):1048-1052. doi: 10.3892/ol.2013.1107. Epub 2013 Jan 7. Oncol Lett. 2013. PMID: 23426604 Free PMC article.
-
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.Mol Oncol. 2019 Feb;13(2):185-201. doi: 10.1002/1878-0261.12396. Epub 2018 Nov 15. Mol Oncol. 2019. PMID: 30353652 Free PMC article.
-
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.Cancer Res. 2008 Jul 15;68(14):5839-48. doi: 10.1158/0008-5472.CAN-07-5771. Cancer Res. 2008. PMID: 18632638 Free PMC article.
-
Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells.Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L328-36. doi: 10.1152/ajplung.90431.2008. Epub 2008 Dec 26. Am J Physiol Lung Cell Mol Physiol. 2009. PMID: 19112101 Free PMC article.
-
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells.Mol Cancer Ther. 2008 Jul;7(7):1993-2002. doi: 10.1158/1535-7163.MCT-08-0088. Mol Cancer Ther. 2008. PMID: 18645009 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous